BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 2866228)

  • 1. The cytotoxic response to murine cytomegalovirus. III. Lymphokine release and cytotoxicity are dependent upon phenotypically similar immune cell populations.
    Sinickas VG; Ashman RB; Hodgkin PD; Blanden RV
    J Gen Virol; 1985 Dec; 66 ( Pt 12)():2551-61. PubMed ID: 2866228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cytotoxic response to murine cytomegalovirus. I. Parameters in vivo.
    Sinickas VG; Ashman RB; Blanden RV
    J Gen Virol; 1985 Apr; 66 ( Pt 4)():747-55. PubMed ID: 2984317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The cytotoxic response to murine cytomegalovirus. II. In vitro requirements for generation of cytotoxic T cells.
    Sinickas VG; Ashman RB; Blanden RV
    J Gen Virol; 1985 Apr; 66 ( Pt 4)():757-65. PubMed ID: 2984318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Development in vitro of cytotoxic lymphocytes against murine cytomegalovirus.
    Ho M; Ashman RB
    Aust J Exp Biol Med Sci; 1979 Aug; 57(4):425-8. PubMed ID: 232415
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The cytotoxic response to murine cytomegalovirus: requirements for the generation of MCMV-specific target cells.
    Sinickas VG; Ashman RB; Blanden RV
    Immunol Cell Biol; 1987 Apr; 65 ( Pt 2)():173-82. PubMed ID: 3038737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inability of interferon to protect virus-infected cells against lysis by natural killer (NK) cells correlates with NK cell-mediated antiviral effects in vivo.
    Bukowski JF; Welsh RM
    J Immunol; 1985 Nov; 135(5):3537-41. PubMed ID: 2413125
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of specific cytotoxic lymphocytes in cellular immunity against murine cytomegalovirus.
    Ho M
    Infect Immun; 1980 Mar; 27(3):767-76. PubMed ID: 6247279
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The inflammatory macrophage response to murine cytomegalovirus in genetically susceptible mice.
    Price P; Winter JG; Shellam GR
    Arch Virol; 1989; 106(1-2):35-50. PubMed ID: 2548459
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The cytolytic T lymphocyte response to the murine cytomegalovirus. I. Distinct maturation stages of cytolytic T lymphocytes constitute the cellular immune response during acute infection of mice with the murine cytomegalovirus.
    Reddehase MJ; Keil GM; Koszinowski UH
    J Immunol; 1984 Jan; 132(1):482-9. PubMed ID: 6317749
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predominant utilization of V beta 8+ T cell receptor genes in the H-2Ld-restricted cytotoxic T cell response against the immediate-early protein pp89 of the murine cytomegalovirus.
    Rodewald HR; Koszinowski UH; Eichmann K; Melchers I
    J Immunol; 1989 Dec; 143(12):4238-43. PubMed ID: 2556481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The immune response of the mouse to lymphocytic choriomeningitis virus. V. High numbers of cytolytic T lymphocytes are generated in the spleen during acute infection.
    Moskophidis D; Assmann-Wischer U; Simon MM; Lehmann-Grube F
    Eur J Immunol; 1987 Jul; 17(7):937-42. PubMed ID: 2886344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Induction of virus specific and H-2 restricted cytotoxic T cells by UV inactivated murine cytomegalovirus.
    Sethi KK; Brandis H
    Arch Virol; 1979; 60(3-4):227-38. PubMed ID: 228635
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The role of LY49 NK cell subsets in the regulation of murine cytomegalovirus infections.
    Tay CH; Yu LY; Kumar V; Mason L; Ortaldo JR; Welsh RM
    J Immunol; 1999 Jan; 162(2):718-26. PubMed ID: 9916691
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Murine cytomegalovirus independently inhibits priming of helper and cytotoxic T lymphocytes.
    Slater JS; Futch WS; Cavanaugh VJ; Campbell AE
    Virology; 1991 Nov; 185(1):132-9. PubMed ID: 1656582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synergistic effect of murine cytomegalovirus on the induction of acute graft-vs-host disease involving MHC class I differences only. Analysis of in vitro T cell function.
    Via CS; Shanley JD; Shearer GM
    J Immunol; 1990 Nov; 145(10):3283-9. PubMed ID: 2172381
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of cyclosporin on major histocompatibility complex-linked resistance to murine cytomegalovirus.
    Lawson CM; Hodgkin PD; Shellam GR
    J Gen Virol; 1989 May; 70 ( Pt 5)():1253-9. PubMed ID: 2543779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An early event in murine cytomegalovirus replication inhibits presentation of cellular antigens to cytotoxic T lymphocytes.
    Campbell AE; Slater JS; Cavanaugh VJ; Stenberg RM
    J Virol; 1992 May; 66(5):3011-7. PubMed ID: 1313914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effect of biological response modifiers on chronic and latent murine cytomegalovirus infections.
    Okada M; Minamishima Y
    Microbiol Immunol; 1987; 31(5):435-47. PubMed ID: 2443815
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymphokine-induced cytotoxicity: characterization of effectors, precursors, and regulatory ancillary cells.
    Ting CC; Yang SS; Hargrove ME
    Cancer Res; 1986 Feb; 46(2):513-8. PubMed ID: 3079663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of T cells in mouse cytomegalovirus myocarditis.
    Lawson CM; O'Donoghue H; Reed WD
    Immunology; 1989 May; 67(1):132-4. PubMed ID: 2544512
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.